Cipla names Dr Mandar Purushottam Vaidya as Additional, Independent Director
New Delhi: Cipla has announced the appointment of Dr. Mandar Purushottam Vaidya as an additional and independent director of the Company for period of 5 years with effect from 29th July 2022 to 28th July 2027 (both days inclusive).
"The Board of the Directors at its meeting held today i.e., on 29th July 2022, has appointed Dr. Mandar Purushottam Vaidya as an additional and independent director of the Company for period of 5 years with effect from 29th July 2022 to 28th July 2027 (both days inclusive)," Cipla stated in a BSE filing.
Dr. Mandar Vaidya is a medical doctor and a management graduate from the Jamnalal Bajaj Institute of Management Studies, India.
He spent 15 years at McKinsey (2002-2017), the last seven as a partner where he co-led the healthcare practice in India and established the hospitals practice for Asia. He has served leading pharmaceutical companies in India and globally, across several areas such as core strategy, manufacturing productivity improvement, R&D productivity, portfolio management, M&A and procurement programs.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.